Dexamethasone-Induced MerTK^+/high M2c Macrophages Exhibit a Preference for Downregulated Gene Expression Profiles

Area of Science:

• Immunology
• Cell Therapy
• Transcriptomics

Background:

• Previous studies showed Dexamethasone (DEX)-induced M2c macrophages expressing MerTK receptor mitigated allograft rejection.
• Limited research exists on the properties and broader applications of adoptive M2c cells.

Purpose of the Study:

• To characterize the transcriptome profile of DEX-induced MerTK+/high M2c macrophages.
• To explore their potential for adoptive cell therapy in autoimmune conditions.

Main Methods:

• Transcriptome profiling of DEX-induced MerTK+/high M2c macrophages.
• Differential gene expression analysis.
• KEGG pathway analysis.

Main Results:

• No significant pathways were identified from upregulated genes.
• Downregulated genes facilitated KEGG construction, highlighting immune tolerance roles.
• Expression of T-cell activation, cytokine modulation, leukocyte recruitment, and MHC-I/II proteins was diminished.

Conclusions:

• DEX-induced MerTK+/high M2c macrophages exhibit downregulated gene expression profiles, indicating immunosuppressive properties.
• These macrophages show potential for adoptive cell therapy in autoimmune diseases like rheumatoid arthritis, inflammatory bowel disease, and type-I diabetes.
• Further research may explore their role in AGE/RAGE signaling pathway in diabetic complications.